- Home
- ASYS vs RLMD Comparison
ASYS vs RLMD Comparison
Compare ASYS & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- RLMD
- Stock Information
- Founded
- ASYS 1981
- RLMD 2004
- Country
- ASYS United States
- RLMD United States
- Employees
- ASYS N/A
- RLMD N/A
- Industry
- ASYS Industrial Machinery/Components
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- RLMD Health Care
- Exchange
- ASYS Nasdaq
- RLMD Nasdaq
- Market Cap
- ASYS 83.0M
- RLMD 66.7M
- IPO Year
- ASYS N/A
- RLMD N/A
- Fundamental
- Price
- ASYS $9.17
- RLMD $2.32
- Analyst Decision
- ASYS
- RLMD Hold
- Analyst Count
- ASYS 0
- RLMD 2
- Target Price
- ASYS N/A
- RLMD $1.00
- AVG Volume (30 Days)
- ASYS 476.5K
- RLMD 526.2K
- Earning Date
- ASYS 08-06-2025
- RLMD 11-06-2025
- Dividend Yield
- ASYS N/A
- RLMD N/A
- EPS Growth
- ASYS N/A
- RLMD N/A
- EPS
- ASYS N/A
- RLMD N/A
- Revenue
- ASYS $83,634,000.00
- RLMD N/A
- Revenue This Year
- ASYS N/A
- RLMD N/A
- Revenue Next Year
- ASYS $12.93
- RLMD N/A
- P/E Ratio
- ASYS N/A
- RLMD N/A
- Revenue Growth
- ASYS N/A
- RLMD N/A
- 52 Week Low
- ASYS $3.20
- RLMD $0.24
- 52 Week High
- ASYS $10.25
- RLMD $3.98
- Technical
- Relative Strength Index (RSI)
- ASYS 59.22
- RLMD 69.58
- Support Level
- ASYS $8.28
- RLMD $1.53
- Resistance Level
- ASYS $10.09
- RLMD $1.75
- Average True Range (ATR)
- ASYS 0.79
- RLMD 0.28
- MACD
- ASYS -0.13
- RLMD 0.06
- Stochastic Oscillator
- ASYS 45.18
- RLMD 62.54
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.